Smith, MA; Culver-Cochran, AE; Adelman, ER; Rhyasen, GW; Ma, A; Figueroa, ME; Starczynowski, DT.
TNFAIP3 Plays a Role in Aging of the Hematopoietic System.
Frontiers in Immunology.
2020;
11.
Schieber, M; Marinaccio, C; Bolanos, LC; Haffey, WD; Greis, KD; Starczynowski, DT; Crispino, JD.
FBXO11 is a candidate tumor suppressor in the leukemic transformation of myelodysplastic syndrome.
Blood Cancer Journal.
2020;
10.
Niederkorn, M; Agarwal, P; Starczynowski, DT.
TIFA and TIFAB: FHA-domain proteins involved in inflammation, hematopoiesis, and disease.
Experimental Hematology.
2020;
90:18-29.
Starczynowski, DT.
HHEX expression drives AML development.
Blood.
2020;
136:1575-1576.
Muto, T; Walker, CS; Choi, K; Hueneman, K; Smith, MA; Gul, Z; Garcia-Manero, G; Ma, A; Zheng, Y; Starczynowski, DT.
Adaptive response to inflammation contributes to sustained myelopoiesis and confers a competitive advantage in myelodysplastic syndrome HSCs.
Nature Immunology.
2020;
21:535-545.
Jones, LM; Melgar, K; Bolanos, L; Hueneman, K; Walker, MM; Jiang, J; Wilson, KM; Zhang, X; Shen, J; Jiang, F; et al.
Targeting AML-associated FLT3 mutations with a type I kinase inhibitor.
Journal of Clinical Investigation.
2020;
130:2017-2023.
Niederkorn, M; Hueneman, K; Choi, K; Varney, ME; Romano, L; Pujato, MA; Greis, KD; Inoue, J; Meetei, R; Starczynowski, DT.
TIFAB Regulates USP15-Mediated p53 Signaling during Stressed and Malignant Hematopoiesis.
Cell Reports.
2020;
30:2776-2790.e6.